Press Releases
Glooko Names Mark Clements, M.D., Ph.D. as Chief Medical and Strategy Officer
Renowned pediatric endocrinologist and researcher brings deep clinical and technical expertise to expanded leadership role Glooko, a leading global diabetes...
Read MoreGlooko Joins Epic Showroom, Expanding Access to Seamless Electronic Health Record Integration for Healthcare Providers
Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, announced today that its...
Glooko and Innovation Zed Partner to Revolutionize Injectable Therapy Management with Digital Companion Apps
Glooko and Innovation Zed partner to develop digital companion apps for injectable therapies for people with diabetes, improving adherence, safety, and...
Glooko Secures Reimbursement for Remote Monitoring of Gestational Diabetes in France
Glooko XT has been approved for reimbursement in France for remote monitoring of gestational diabetes (GDM).
Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing
Hedia and Glooko partner to improve diabetes care with personalized insulin dosing, supporting people with Type 1 and Type 2 diabetes.
Glooko Secures $100 Million Series F Financing and Appoints Mike Alvarez as Chief Executive Officer
Glooko raises $100M in Series F funding and names Mike Alvarez as CEO to drive the next phase of growth in digital health and diabetes management.
Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors
Glooko announced the appointment of Enrique Conterno to its Board of Directors.